Income Statement (TTM)
Influx Healthtech Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2022 03-31 |
2023 03-31 |
2024 03-31 |
2025 03-31 |
|
|---|---|---|---|---|
| Revenue | 592 | 761 | 1,000 | 1,049 |
| Change (%) | 28.47 | 31.44 | 4.89 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 456 | 529 | 656 | 639 |
| Change (%) | 15.83 | 24.10 | -2.52 | |
| % of Revenue | 77.09 | 69.50 | 65.62 | 60.99 |
| Gross Operating Profit | 136 | 232 | 344 | 409 |
| Change (%) | 70.99 | 48.16 | 19.03 | |
| % of Revenue | 22.91 | 30.50 | 34.38 | 39.01 |
| SG&A | 40 | 61 | 82 | 100 |
| Change (%) | 54.40 | 33.79 | 21.99 | |
| % of Revenue | 6.72 | 8.08 | 8.22 | 9.56 |
| R&D | ||||
| Change (%) | ||||
| % of Revenue | ||||
| OpEx | 532 | 663 | 848 | 870 |
| Change (%) | 24.68 | 28.02 | 2.56 | |
| % of Revenue | 89.78 | 87.13 | 84.87 | 82.98 |
| Operating Income | 60 | 98 | 151 | 178 |
| Change (%) | 61.81 | 54.59 | 17.96 | |
| % of Revenue | 10.22 | 12.87 | 15.13 | 17.02 |
| Interest Expense | -0 | -0 | -2 | -0 |
| Change (%) | 84.62 | 1,685.42 | -99.47 | |
| % of Revenue | -0.01 | -0.01 | -0.17 | -0.00 |
| Net Income | 44 | 72 | 111 | 134 |
| Change (%) | 62.20 | 54.64 | 20.11 | |
| % of Revenue | 7.49 | 9.46 | 11.13 | 12.75 |
Source: Capital IQ
